Abstract
Spontaneously hypertensive heart failure rats (SHHF) appear to constitute an original model for analyzing the evolution of the metabolic syndrome towards heart failure. This study aimed to characterize early cardiac dysfunction and remodeling in SHHF rats: (1) as compared with spontaneously hypertensive rats (SHR) and with a control group of Kyoto rats (WKY), and (2) by using the 3-dimensional quantitative analysis provided by acipimox-enhanced positron emission tomography (PET) with 18F-fluorodesoxyglucose (FDG). Left ventricular (LV) ejection fraction (EF) and volume were quantified by automatic software on the FDG-PET images recorded in SHR (n = 20), SHHF (n = 18) and WKY-rats (n = 19) at ages 3 or 10 months old. Arterial blood pressure was determined by cardiac catheterization and cardiac fibrosis was quantified after sacrifice. Blood pressure was similarly elevated in SHR and SHHF rats (respective systolic blood pressures at 10-months: 199 ± 39 vs. 205 ± 2 mmHg), but SHHF rats had higher body mass than SHR rats (at 10-months, 630 ± 36 vs. 413 ± 27 g, p < 0.05) and higher blood levels of cholesterol and of triglycerides. At 3 months, cardiac parameters did not show significant differences between groups but at 10-months, SHHF and SHR rats exhibited an enhancement in myocardial mass and fibrosis associated with a clear decline in LV-EF (SHHF: 46 ± 6 %; SHR: 47 ± 5 %) as compared with WKY (56 ± 6 %, p < 0.01 for both comparisons). Cardiac remodeling of SHHF rats was clearly observable by FDG-PET from the age of 10-months, but in a similar way to that observed for SHR rats, suggesting a predominant role of hypertension.
Similar content being viewed by others
References
Schillaci G, Pirro M, Vaudo G, Gemelli F, Marchesi S, Porcellati C, Mannarino E (2004) Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol 43:1817–1822
McCune SA, Baker PB, Stills JHF (1990) SHHF/Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure. ILAR News 32:23–27
Saliaris AP, Amado LC, Minhas KM, Schuleri KH, Lehrke S, St John M, Fitton T, Barreiro C, Berry C, Zheng M, Kozielski K, Eneboe V, Brawn J, Hare JM (2007) Chronic allopurinol administration ameliorates maladaptive alterations in Ca2+ cycling proteins and beta adrenergic hyporesponsiveness in heart failure. Am J Physiol Heart Circ Physiol 292(3):H1328–H1335
Haas GJ, McCune SA, Brown DM, Cody RJ (1995) Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model. Am Heart J 130:806–811
Johnsen D, Kacimi R, Anderson BE, Thomas TA, Said S, Gerdes MA (2005) Protein kinase C isozymes in hypertension and hypertrophy: insight from SHHF rat hearts. Mol Cell Biochem 270:63–69
Anderson KM, Eckhart AD, Willette RN, Koch WJ (1999) The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats. Hypertension 33:402–407
Sridhar A, Dech SJ, Lacombe VA, Elton TS, McCune SA, Altschuld RA, Carnes CA (2006) Abnormal diastolic currents in ventricular myocytes from spontaneous hypertensive heart failure rats. Am J Physiol Heart Circ Physiol 291:2192–2198
Tamura T, Onodera T, Said S, Gerdes AM (1998) Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat. J Mol Cell Cardiol 30:2175–2181
Heyen JR, Blasi ER, Nikula K, Rocha R, Daust HA, Frierdich G, Van Vleet JF, De Ciechi P, McMahon EG, Rudolph AE (2002) Structural, functional, and molecular characterization of the SHHF model of heart failure. Am J Physiol Heart Circ Physiol 283:1775–1784
Schultz RL, Swallow JG, Waters RP, Kuzman JA, Redetzke RA, Said S, De Escobar GM, Gerdes AM (2007) Effects of excessive long-term exercise on cardiac function and myocyte remodelling in hypertensive heart failure rats. Hypertension 50:410–416
Poussier S, Maskali F, Tran N, Person C, Maureira P, Boutley H, Karcher G, Lacolley P, Régnault V, Fay R, Marie PY (2010) ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox. Eur J Nucl Med Mol Imaging 37:1745–1750
Bousquenaud M, Maskali F, Poussier S, Marie PY, Boutley H, Karcher G, Wagner DR, Devaux Y (2012) Acipimox-enhanced (18F)-fluorodeoxyglucose positron emission tomography for characterizing and predicting early remodeling in the rat infarct model. Int J Cardiovasc Imaging 28(6):1407–1415
Bousquenaud M, Maskali F, Poussier S, Zangrando J, Marie PY, Boutley H, Fay R, Karcher G, Wagner DR, Devaux Y (2013) Cardioprotective effects of adenosine within the border and remote areas of myocardial infarction. EJNMMI Res 3(1):65
Maskali F, Franken PR, Poussier S, Tran N, Vanhove C, Boutley H, Le Gall H, Karcher G, Zannad F, Lacolley P, Marie PY (2006) Initial infarct size predicts subsequent cardiac remodeling in the rat infarct model: an in vivo serial pinhole gated SPECT study. J Nucl Med 47(2):337–344
Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M (2002) Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation 106:2848–2853
Sloboda N, Fève B, Thornton SN, Nzietchueng R, Regnault V, Simon G, Labat C, Louis H, Max JP, Muscat A, Osborne-Pellegrin M, Lacolley P, Benetos A (2012) Fatty acids impair endothelium-dependent vasorelaxation: a link between obesity and arterial stiffness in very old Zucke rats. J Gerontol A Biol Sci Med Sci 67(9):927–938
Maskali F, Poussier S, Marie PY, Tran N, Antunes L, Olivier P, Plenat F, Maîtrejean S, Zannad F, Karcher G (2005) High-resolution simultaneous imaging of SPECT, PET, and MRI tracers on histologic sections of myocardial infarction. J Nucl Cardiol 12(2):229–230
Reffelmann T, Kloner RA (2003) Transthoracic echocardiography in rats. Evaluation of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging. Basic Res Cardiol 98:275–284
Poornima I, Brown SB, Bhashyam S, Parikh P, Bolukoglu H, Shannon RP (2008) Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat. Circ Heart Fail 1:153–160
Arias T, Chen J, Fayad ZA, Fuster V, Hajjar RJ, Chemaly ER (2013) Comparison of echocardiographic measurements of left ventricular volumes to full volume magnetic resonance imaging in normal and diseased rats. J Am Soc Echocardiogr 26(8):910–918
Richardson JD, Bertaso AG, Frost L, Psaltis PJ, Carbone A, Koschade B, Wong DT, Nelson AJ, Paton S, Williams K, Azarisman S, Worthley MI, Teo KS, Gronthos S, Zannettino AC, Worthley SG (2013) Cardiac magnetic resonance, transthoracic and transoesophageal echocardiography: a comparison of in vivo assessment of ventricular function in rats. Lab Anim 47(4):291–300
Linz D, Hohl M, Mahfoud F, Reil JC, Linz W, Hübschle T, Juretschke HP, Neumann-Häflin C, Rütten H, Böhm M (2012) Cardiac remodelling and myocardial dysfunction in obese spontaneously hypertensive rats. J Transl Med 10(10):187
Oliveira Junior SA, Dal Pai-Silva M, Martinez PF, Lima-Leopoldo AP, Campos DH, Leopoldo AS, Okoshi MP, Okoshi K, Padovani CR, Cicogna AC (2010) Diet-induced obesity causes metabolic, endocrine and cardiac alterations in spontaneously hypertensive rats. Med Sci Monit 16 (12):BR367-73
Gómez-Garre D, González-Rubio ML, Muñoz-Pacheco P, Caro-Vadillo A, Aragoncillo P, Fernández-Cruz A (2010) Rosuvastatin added to standard heart failure therapy improves cardiac remodelling in heart failure rats with preserved ejection fraction. Eur J Heart Fail 12:903–912
Cittadini A, Napoli R, Monti MG, Rea D, Longobardi S, Netti PA, Walser M, Samà M, Aimaretti G, Isgaard J, Saccà L (2012) Metformin prevents the development of chronic heart failure in the SHHF rat model. Diabetes 61:944–953
Hasegawa S, Kusuoka H, Uehara T, Yamaguchi H, Hori M, Nishimura T (1998) Glucose tolerance and myocardial F-18 fluorodeoxyglucose uptake in normal regions in coronary heart disease patients. Ann Nucl Med 12(6):363–368
Mäki M, Nuutila P, Laine H, Voipio-Pulkki LM, Haaparanta M, Solin O, Knuuti JM (1997) Myocardial glucose uptake in patients with NIDDM and stable coronary artery disease. Diabetes 46(9):1491–1496
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maskali, F., Poussier, S., Louis, H. et al. Assessment of the early stage of cardiac remodeling of spontaneously hypertensive heart failure rats using the quantitative 3-dimensional analysis provided by acipimox-enhanced FDG-PET. Int J Cardiovasc Imaging 30, 449–456 (2014). https://doi.org/10.1007/s10554-013-0350-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-013-0350-3